BioAdaptives, Inc. (OTC: BDPT) has announced the launch of MyndRenew™, a nighttime dietary supplement designed to support sleep quality and the brain’s overnight recovery processes. The company describes this as addressing a critical gap in cognitive health, noting that more than one-third of U.S. adults report insufficient sleep. MyndRenew is part of the MyndSystem™ platform, which aims to provide full 24-hour cognitive support with formulations tailored to both daytime performance and nighttime recovery.
The formulation includes 13 ingredients selected from published scientific literature, including magnesium glycinate, apigenin, PEA, and lion’s mane mushroom extract. These ingredients are intended to support sleep pathways, cellular repair, stress regulation, and neuroprotection. MyndRenew complements the company’s daytime product, MyndMed™, with both products positioned to address distinct physiological demands across the daily cycle.
The launch of MyndRenew comes at a time when sleep deprivation is recognized as a widespread public health issue. According to the Centers for Disease Control and Prevention, more than one-third of U.S. adults report getting less than the recommended seven hours of sleep per night. Chronic sleep deficiency has been linked to a range of health problems, including cognitive decline, impaired memory, and increased risk of chronic diseases. By focusing on the brain’s overnight recovery processes, BioAdaptives aims to offer a solution that may help mitigate these risks.
BioAdaptives develops and markets science-based health and wellness products for human and animal use. Its formulations are rooted in published research across nutrition, adaptogens, and cellular health, with a focus on supporting normal physiological function. The company’s approach emphasizes evidence-based ingredients to address specific health needs.
The MyndSystem platform represents a holistic strategy for cognitive health, recognizing that the brain’s needs differ between waking hours and sleep. During the day, MyndMed targets mental clarity and focus, while MyndRenew supports the restorative processes that occur during sleep. This dual approach may appeal to consumers seeking comprehensive cognitive support.
Industry observers note that the dietary supplement market for sleep and cognitive health is growing, driven by increasing awareness of the importance of sleep for overall well-being. Products that combine multiple evidence-based ingredients could differentiate themselves in a crowded market. BioAdaptives’ reliance on published scientific literature for its formulations may enhance credibility with health-conscious consumers.
For more information, visit the company’s website at www.bioadaptives.com. The full press release is available at https://ibn.fm/jubib.
